Articles |
the Department of Molecular Biology (K.A.P., G.F.A., D.K.W.H., S.-L.Y.F., J.A.W.), Holland Laboratory, American Red Cross, Rockville, Md, and the Department of Biochemistry and Molecular Biology (J.A.W.), George Washington University Medical Center, Washington, DC.
Correspondence to Dr Jeffrey A. Winkles, Department of Molecular Biology, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855. E-mail winkles@hlsun.red-cross.org.
Heparin-binding epidermal growth factorlike growth factor (HB-EGF) is a vascular smooth muscle cell (SMC) mitogen and chemotactic factor that is expressed by endothelial cells, SMCs, monocytes/macrophages, and T lymphocytes. Both the membrane-anchored HB-EGF precursor and the secreted mature HB-EGF protein are biologically active; thus, HB-EGF may stimulate SMC growth via autocrine, paracrine, and juxtacrine mechanisms. In the present study, we report that HB-EGF treatment of serum-starved rat aortic SMCs can induce fibroblast growth factor (FGF)-2 (basic FGF) gene expression but not FGF-1 (acidic FGF) gene expression. Increased FGF-2 mRNA expression is first detectable at 1 hour after HB-EGF addition, and maximal FGF-2 mRNA levels, corresponding to an
46-fold level of induction, are present at 4 hours. The effect of HB-EGF on FGF-2 mRNA levels appears to be mediated primarily by a transcriptional mechanism and requires de novo synthesized proteins. HB-EGF induction of FGF-2 mRNA levels can be inhibited by treating cells with the anti-inflammatory glucocorticoid dexamethasone or the glycosaminoglycan heparin. Finally, Western blot analyses indicate that HB-EGFtreated SMCs also produce an increased amount of FGF-2 protein. These results indicate that HB-EGF expressed at sites of vascular injury or inflammation in vivo may upregulate FGF-2 production by SMCs.
Key Words: heparin-binding epidermal growth factorlike growth factor smooth muscle cell fibroblast growth factor dexamethasone heparin
This article has been cited by other articles:
![]() |
J. Liu, C. B. Rich, J. A. Buczek-Thomas, M. A. Nugent, M. P. Panchenko, and J. A. Foster Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1106 - L1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ghiselli, J. Chen, M. Kaou, H. Hallak, and R. Rubin Ethanol Inhibits Fibroblast Growth Factor-Induced Proliferation of Aortic Smooth Muscle Cells Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1808 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Gerthoffer and C. A. Singer Secretory Functions of Smooth Muscle: Cytokines and Growth Factors Mol. Interv., November 1, 2002; 2(7): 447 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogata, N. Yorioka, and N. Kohno Glucose and Prednisolone Alter Basic Fibroblast Growth Factor Expression in Peritoneal Mesothelial Cells and Fibroblasts J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2787 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, A. B. Rice, K. Adler, P. Sannes, L. Martin, W. Gladwell, J.-S. Koo, T. E. Gray, and J. C. Bonner Vanadium Stimulates Human Bronchial Epithelial Cells to Produce Heparin-Binding Epidermal Growth Factor-Like Growth Factor . A Mitogen for Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 123 - 131. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |